MFC Stock Analysis: Buy, Sell, or Hold?
MFC - Manulife Financial Corp.
$41.29
0.00 (0.00%)
▲
5d:
-0.17%
30d:
+5.2%
90d:
+13.06%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When MFC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MFC shows positive signals but monitor for confirmation. Market pricing in 2.7% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: MFC shows positive signals but monitor for confirmation. Market pricing in 2.7% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.59
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$33.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MFC is currently trading at $41.29, which is considered slightly high relative to its 30-day fair value range of $39.46 to $41.20. The stock's valuation (Forward PE: 8.4) is in line with its historical norms (7.8). At these levels, the market is pricing in 2.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MFC is in a strong downtrend. The price is approaching resistance at $39.37. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MFC is in a strong downtrend. The price is approaching resistance at $39.37. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$39.46 -
$41.20
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($42.34)
- NEUTRAL: Market pricing in 2.7% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$39.46 -
$41.20
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$36.84
Resistance Level
$39.37
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.40
Wall Street Target
$42.34
(+2.5%)
Revenue Growth (YoY)
12.1%
Earnings Growth (YoY)
161.6%
Profit Margin
20.0%
Valuation Premium vs History
+2.7% premium
PE vs Historical
8.4 vs 7.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.7%
(market-implied from PE analysis)
1-Year Target
$42.40
(+3%)
2-Year Target
$43.55
(+6%)
3-Year Target
$44.73
(+8%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$41.53
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.7%)
$145.20
(+252%)
Base:
(SPY PE: 8.4, Growth: 10.7%)
$56.01
(+36%)
Bear:
(PE: 7.1, Growth: 10.7%)
$47.61
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 16.92 | Current EPS (TTM): $2.44
Bull Case
$90.84
(+120%)
Analyst growth 100.0%, PE expands to 18.6
Base Case
$82.58
(+100%)
Market implied 100.0%, PE stable at 16.9
Bear Case
$28.08
(-32%)
Severe decline -20.0%, PE contracts to 14.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 6:16 PM ET
Data refreshes hourly during market hours. Next update: 7:16 PM
Data refreshes hourly during market hours. Next update: 7:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MFC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$95 | 59 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$100 | 58 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$180 | 60 HOLD |
|
LNC
Lincoln National Corpora… |
HOLD
13 analysts |
$44 | 61 BUY |
